Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications (vol 1, pg 172, 2007)

被引：0
|
作者：
Suzuki, Mika [1 ]
Tarin, David [1 ]
机构：
[1] Univ Calif San Diego, Dept Pathol, Rebecca & John Moores UCSD Comprehens Canc Ctr, La Jolla, CA 92093 USA
来源：
MOLECULAR ONCOLOGY | 2008年 / 1卷 / 04期
关键词：
D O I：
10.1016/j.molonc.2007.11.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [31] Relationship between gene and tumor marker expression in primary breast carcinoma and lymph node metastases of the same patient
    Andres, Sarah A.
    Wittliff, James L.
    CANCER RESEARCH, 2011, 71
  • [32] Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases
    Hague, A
    Packham, G
    Huntley, S
    Shefford, K
    Eveson, JW
    JOURNAL OF PATHOLOGY, 2002, 197 (01): : 60 - 71
  • [33] Prediction of lymph node involvement in breast cancer from primary tumour tissue using gene expression profiling
    Smeets, A.
    Daemen, A.
    Van den Bempt, I.
    Gevaert, O.
    Wildiers, H.
    Drijkoningen, R.
    Van Hummelen, P.
    Paridaens, R.
    Sotiriou, C.
    Christiaens, M. R.
    EJC SUPPLEMENTS, 2010, 8 (03): : 107 - 107
  • [34] Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases
    Nogami, Tomohiro
    Shien, Tadahiko
    Tanaka, Takehiro
    Nishiyama, Keiko
    Mizoo, Taeko
    Iwamto, Takayuki
    Ikeda, Hirokuni
    Taira, Naruto
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    BREAST CANCER, 2014, 21 (01) : 58 - 65
  • [35] EXPRESSION OF MDR1 GENE IN HUMAN BREAST PRIMARY TUMORS AND METASTASES
    HENNEQUIN, E
    DELVINCOURT, C
    POURNY, C
    JARDILLIER, JC
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (03) : 267 - 274
  • [36] Gene expression profiling in breast cancer: A clinical perspective (vol 22, pg 109, 2013)
    Arpino, Grazia
    Generali, Daniele
    Sapino, Anna
    Del Mastro, Lucia
    Frassoldati, Antonio
    de laurentiis, Michelino
    Pronzato, Paolo
    Mustacchi, Giorgio
    Cazzaniga, Marina
    De Placido, Sabino
    Conte, Pierfranco
    Cappelletti, Mariarosa
    Zanoni, Vanessa
    Antonelli, Andrea
    Martinotti, Mario
    Puglisi, Fabio
    Berruti, Alfredo
    Bottini, Alberto
    Dogliotti, Luigi
    BREAST, 2016, 25 : 86 - 86
  • [37] Expression of cancer stem cell (CSC) markers in primary tumors (PT) and matched lymph node metastases (LNM) in breast cancer patients
    Zaczek, A.
    Bednarz-Knoll, N.
    Markiewicz, A.
    Nastaly, P.
    Seroczynska, B.
    Skokowski, J.
    Szade, J.
    Welnicka-Jaskiewicz, M.
    Jassem, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S213 - S213
  • [38] Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs
    A. Smeets
    A. Daemen
    I. Vanden Bempt
    O. Gevaert
    B. Claes
    H. Wildiers
    R. Drijkoningen
    P. Van Hummelen
    D. Lambrechts
    B. De Moor
    P. Neven
    C. Sotiriou
    T. Vandorpe
    R. Paridaens
    M. R. Christiaens
    Breast Cancer Research and Treatment, 2011, 129 : 767 - 776
  • [39] Gene expression profiling of lymph node positive-negative metastasis of primary breast cancer in Saudi Arabian patients
    Adnan Merdad
    Sajjad Karim
    Hans-Juergen Schulten
    Ashraf Dallol
    Abdelbaset S Buhmeida
    Fatima Al-Thubaity
    Manar M Ata
    Mamdooh A Gari
    Adeel GA Chaudhary
    Adel M Abuzenadah
    Mohammed H Al-Qahtani
    BMC Genomics, 15 (Suppl 2)
  • [40] Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs
    Smeets, A.
    Daemen, A.
    Vanden Bempt, I.
    Gevaert, O.
    Claes, B.
    Wildiers, H.
    Drijkoningen, R.
    Van Hummelen, P.
    Lambrechts, D.
    De Moor, B.
    Neven, P.
    Sotiriou, C.
    Vandorpe, T.
    Paridaens, R.
    Christiaens, M. R.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (03) : 767 - 776
12345